Analysis of chimerism during the early period after allogeneic peripheral stem cell transplantation

Clin Lab Haematol. 2001 Dec;23(6):401-6. doi: 10.1046/j.1365-2257.2001.00408.x.

Abstract

As there are few reports on early evaluation of chimerism, we assessed fluorescence short tandem repeats (STR) by polymerase chain reaction (PCR) assays to analyse donor and recipient characteristics at early time points after peripheral stem cell transplantation (PBSCT). Peripheral blood of 13 patients was analysed in 1- to 2-day intervals starting from the day of PBSCT. Donor and recipient allelic patterns were determined by a commercially available multiplex STR assay that simultaneously evaluates four or five gene loci. Mixed chimerism appeared in all patients during days 1-9 after transplantation and preceded haematologic engraftment for 3-12 days. Even patients without myeloablative conditioning therapy (n=4) revealed donor allelic patterns within 1-5 days. Nine patients changed during the following days to a complete donor allelic pattern and had an uncomplicated post-transplant disease course. Four patients did not consistently retain complete donor chimerism; two of them relapsed within the next 3 months, one died from septicemia within 7 days, and the fourth, transplanted for aplastic anaemia, is still in complete remission. Overall, STR analysis using a simple and comparatively cheap multiplex system permits the detection of chimerism very early after transplantation and may provide relevant information that correlates with the clinical follow-up.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Alleles
  • Blood Cells
  • Female
  • Follow-Up Studies
  • Graft Survival
  • Hematologic Neoplasms / complications
  • Hematologic Neoplasms / therapy
  • Humans
  • Male
  • Polymerase Chain Reaction
  • Prognosis
  • Reagent Kits, Diagnostic / standards*
  • Sensitivity and Specificity
  • Stem Cell Transplantation / mortality*
  • Tandem Repeat Sequences
  • Time Factors
  • Transplantation Chimera*
  • Transplantation, Homologous / mortality

Substances

  • Reagent Kits, Diagnostic